We are in the middle of the rollout of health insurance exchanges of the Patient Protection and Affordable Care Act (PPACA), and there are a few significant lessons the healthcare industry, the U.S. Department of Health and Human Services (HHS) and the Centers for Medicare & Medicaid Services (CMS) should keep in mind as industry compliance with ICD-10 is sought.
The industry continues to conduct surveys to monitor the ICD-10 readiness of providers, vendors, and payers, however, there are very few activities involving a major player in this regulatory event: the consumer. We know that we are beginning to see increased collaborative activity among providers and payers seeking to align and test for ICD-10 remediation and transition. But where is the consumer in this transition and testing? What will the impact to the consumer be? Do we wait until October 2014 to test the impact on the consumer, much like we have witnessed with the PPACA, or as an industry, do we begin the dialogue, creating a platform through which we can focus attention to the most important player in the business of healthcare, the patient?